NKGEN BIOTECH INC. - COMMON STOCK

0,5166

24-января-25 16:45:00

15 мин. задержка

Акции

-0,0035

-0,67%

Сегодняшний диапазон

0,4940 - 0,5324

ISIN

N/A

Источник

NASDAQ

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

11 апр 2024 08:05:02 Источник Nasdaq GlobeNewswire
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

25 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire
NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference

04 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

28 дек 2023 16:05:14 Источник Nasdaq GlobeNewswire
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

27 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

14 ноя 2023 16:48:03 Источник Nasdaq GlobeNewswire
NKGen Biotech Presented Phase I Clinical Trial Data at the 16th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

26 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

24 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

19 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech Presents Interim Phase I Trial Data at the XXVI World Congress of Neurology (WCN) Annual Meeting 2023

17 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Announces Poster Presentation at the XXVI World Congress of Neurology (WCN) Annual Meeting 2023

11 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
NKGen Biotech, Inc. Announces Closing of Business Combination

02 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.